Amikacin Liposome Inhalation Suspension: A Review in Mycobacterium avium Complex Lung Disease (vol 79, pg 555, 2019)

被引:1
|
作者
Shirley, Matt [1 ]
机构
[1] Springer, Private Bag 65901, Auckland 0754, New Zealand
关键词
D O I
10.1007/s40265-019-01111-2
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The article Amikacin Liposome Inhalation Suspension: A Review in Mycobacterium avium Complex Lung Disease.
引用
收藏
页码:791 / 791
页数:1
相关论文
共 50 条
  • [11] Amikacin liposome inhalation suspension clinical benefit-risk assessment for refractory Mycobacterium avium complex lung disease
    Marras, Theodore K.
    Hassan, Mariam
    Mange, Kevin C.
    Ciesielska, Monika
    Murthy, Shilpa Dhar
    Jumadilova, Zhanna
    Chatterjee, Anjan
    ERJ OPEN RESEARCH, 2022, 8 (03)
  • [12] Effects of Amikacin Liposome Inhalation Suspension and Amikacin Resistance Development in Patients With Refractory Mycobacterium avium Complex Pulmonary Disease
    Kurahara, Yu
    Yoshida, Shiomi
    Osugi, Asami
    Tanaka, Yuya
    Kobayashi, Takehiko
    Mitsuhashi, Toshiharu
    Kawasaki, Yohei
    Mitarai, Satoshi
    Tsuyuguchi, Kazunari
    OPEN FORUM INFECTIOUS DISEASES, 2025, 12 (03):
  • [13] Acquisition of Amikacin Resistance during Amikacin Liposome Inhalation Suspension Add-on Therapy for Mycobacterium avium Complex Pulmonary Disease
    Sano, Hirohito
    Fujino, Naoya
    Numakura, Tadahisa
    Yamada, Mitsuhiro
    Tode, Naoki
    Sugiura, Hisatoshi
    ANNALS OF THE AMERICAN THORACIC SOCIETY, 2024, 21 (03) : 526 - 529
  • [14] Real-World Outcomes of Amikacin Liposome Inhalation Suspension for Refractory Mycobacterium avium Complex Pulmonary Disease
    Kim, Bo-Guen
    Kim, Sae Rom
    Jhun, Byung Woo
    TUBERCULOSIS AND RESPIRATORY DISEASES, 2024, 87 (02) : 202 - 205
  • [15] Amikacin Liposome Inhalation Suspension in the Real-World Management of Refractory Mycobacterium avium Complex Pulmonary Disease
    Yanagihara, Toyoshi
    Ogata, Hiroaki
    Mori, Asami
    Kadowaki, Masako
    Moriuchi, Yuki
    Ishimatsu, Akiko
    Otsuka, Junji
    Taguchi, Kazuhito
    Moriwaki, Atushi
    Yoshida, Makoto
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2024, 16 (03)
  • [16] EXTENSION STUDY OF AMIKACIN LIPOSOME INHALATION SUSPENSION (ALIS) FOR TREATMENT-REFRACTORY LUNG DISEASE CAUSED BY MYCOBACTERIUM AVIUM COMPLEX (MAC)
    Winthrop, Kevin
    Eagle, Gina
    Morimoto, Kozo
    Castellotti, Paola Francesca
    O'Donnell, Anne
    Ruoss, Stephen
    Aksamit, Timothy
    Nezamis, James
    Griffith, David
    CHEST, 2018, 154 (04) : 182A - 183A
  • [17] In reply-Amikacin Liposome Inhalation Suspension as a Treatment Option for Refractory Nontuberculous Mycobacterial Lung Disease Caused by Mycobacterium avium Complex
    Shulha, Jennifer
    MAYO CLINIC PROCEEDINGS, 2020, 95 (01) : 202 - 202
  • [18] Amikacin liposome and Mycobacterium avium complex: A systematic review
    Zangiabadian, Moein
    Malekshahian, Donya
    Arabpour, Erfan
    Abadi, Sahel Shafiee Dolat
    Yazarlou, Fartous
    Bostanghadiri, Narjess
    Centis, Rosella
    Aghababa, AmirHossein Akbari
    Farahbakhsh, Mohammad
    Nasiri, Mohammad Javad
    Sotgiu, Giovanni
    Migliori, Giovanni Battista
    PLOS ONE, 2022, 17 (12):
  • [19] Effectiveness of Amikacin liposome inhalation suspension for refractory Mycobacterium avium complex pulmonary disease at 6 months post initiation
    Urabe, Naohisa
    Sakamoto, Susumu
    Tokita, Nozomi
    Yoshida, Hiromichi
    Usui, Yusuke
    Shimizu, Hiroshige
    Sekiya, Muneyuki
    Miyoshi, Shion
    Nakamura, Yasuhiko
    Isobe, Kazutoshi
    Kishi, Kazuma
    BMC PULMONARY MEDICINE, 2024, 24 (01):
  • [20] Amikacin Liposome Inhalation Suspension for Mycobacterium avium Complex Lung Disease A 12-Month Open-Label Extension Clinical Trial
    Winthrop, Kevin L.
    Flume, Patrick A.
    Thomson, Rachel
    Mange, Kevin C.
    Yuen, Dayton W.
    Ciesielska, Monika
    Morimoto, Kozo
    Ruoss, Stephen J.
    Codecasa, Luigi R.
    Yim, Jae-Joon
    Marras, Theodore K.
    van Ingen, Jakko
    Wallace, Richard J., Jr.
    Brown-Elliott, Barbara A.
    Coulter, Chris
    Griffith, David E.
    ANNALS OF THE AMERICAN THORACIC SOCIETY, 2021, 18 (07) : 1147 - 1157